C
Carlo A. J. M. Gaillard
Researcher at Utrecht University
Publications - 179
Citations - 6723
Carlo A. J. M. Gaillard is an academic researcher from Utrecht University. The author has contributed to research in topics: Kidney disease & Anemia. The author has an hindex of 41, co-authored 174 publications receiving 5929 citations. Previous affiliations of Carlo A. J. M. Gaillard include University of Groningen & University of Mississippi Medical Center.
Papers
More filters
Journal ArticleDOI
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Iain C. Macdougall,Andreas J. Bircher,Kai-Uwe Eckardt,Gregorio T. Obrador,Carol A. Pollock,Carol A. Pollock,Peter Stenvinkel,Dorine W. Swinkels,Christoph Wanner,Günter Weiss,Glenn M. Chertow,John W. Adamson,Tadao Akizawa,Stefan D. Anker,Michael Auerbach,Peter Bárány,Anatole Besarab,Sunil Bhandari,Ioav Cabantchik,Alan J. Collins,Daniel W. Coyne,Angel L.M. de Francisco,Steven Fishbane,Carlo A. J. M. Gaillard,Tomas Ganz,David Goldsmith,Chaim Hershko,Ewa A. Jankowska,Kirsten L. Johansen,Kamyar Kalantar-Zadeh,Philip A. Kalra,Bertram L. Kasiske,Francesco Locatelli,Jolanta Malyszko,Gert Mayer,Lawrence P. McMahon,Ashraf Mikhail,Elizabeta Nemeth,Amy Barton Pai,Patrick S. Parfrey,Roberto Pecoits-Filho,Simon D. Roger,Guy Rostoker,Jacques Rottembourg,Ajay K. Singh,Itzchak Slotki,Bruce Spinowitz,Der Cherng Tarng,Francesca Tentori,Jorge E. Toblli,Yusuke Tsukamoto,Nosratola D. Vaziri,Wolfgang C. Winkelmayer,David C. Wheeler,Elena Zakharova +54 more
TL;DR: An expert group was convened to assess the benefits and risks of parenteral iron, and to provide strategies for its optimal use while mitigating the risk for acute reactions and other adverse effects.
Journal ArticleDOI
Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals
Rob J. L. Willems,Wieger L. Homan,Janetta Top,Marga Van Santen-Verheuvel,David Tribe,Xenia Manzioros,Carlo A. J. M. Gaillard,Christina M. J. E. Vandenbroucke-Grauls,Ellen M. Mascini,Eric van Kregten,Jan D. A. van Embden,Marc J. M. Bonten +11 more
TL;DR: A specific E. faecium subpopulation genetically distinct from non-epidemic VREF isolates was found to be the cause of the hospital epidemics in all three continents and the Esp protein could be a new target for antibacterial therapy.
Journal ArticleDOI
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
Charlotte E. van Iperen,Carlo A. J. M. Gaillard,Rob J. Kraaijenhagen,Branko Braam,Joannes J. M. Marx,Albert van de Wiel +5 more
TL;DR: Endogenous EPO concentrations are low in critically ill patients, but the bone marrow of these patients is able to respond to exogenous epoetin alfa, as shown by elevated concentrations of reticulocytes and serum transferrin receptors.
Journal ArticleDOI
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Iain C. Macdougall,Andreas Bock,Fernando Carrera,Kai-Uwe Eckardt,Carlo A. J. M. Gaillard,David B. Van Wyck,Bernard Roubert,Jacqueline G. Nolen,Simon D. Roger +8 more
TL;DR: Compared with oral iron, IV FCM targeting a ferritin of 400–600 µg/L quickly reached and maintained Hb level, and delayed and/or reduced the need for other anaemia management including ESAs.
Journal ArticleDOI
Indications for antibiotic use in ICU patients: a one-year prospective surveillance.
Dennis C J J Bergmans,M. J. M. Bonten,Carlo A. J. M. Gaillard,F. H. Van Tiel,S. Van Der Geest,P. W. De Leeuw,Ellen E. Stobberingh +6 more
TL;DR: Almost all antibiotics prescribed were for intubated patients and for BPI, which means that prevention of respiratory tract infections is probably the most effective mode to reduce antibiotic use.